Targeted Deletion of Centrin in Leishmania braziliensis Using CRISPR-Cas9-Based Editing
Leishmania braziliensis is the main causative agent of Tegumentary Leishmaniasis in the Americas. However, difficulties related to genome manipulation, experimental infection, and parasite growth have so far limited studies with this species. CRISPR-Cas9-based technology has made genome editing more...
Main Authors: | Rohit Sharma, Francys Avendaño Rangel, João Luís Reis-Cunha, Larissa Pinheiro Marques, Claudio P. Figueira, Pedro B. Borba, Sayonara M. Viana, Tom Beneke, Daniella C. Bartholomeu, Camila I. de Oliveira |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-02-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2021.790418/full |
Similar Items
-
Immunization with <i>centrin</i>-Deficient <i>Leishmania braziliensis</i> Does Not Protect against Homologous Challenge
by: Francys Avendaño-Rangel, et al.
Published: (2024-03-01) -
Generation and Characterization of a Dual-Reporter Transgenic Leishmania braziliensis Line Expressing eGFP and Luciferase
by: Rohit Sharma, et al.
Published: (2020-01-01) -
LeishIF4E-5 Is a Promastigote-Specific Cap-Binding Protein in <i>Leishmania</i>
by: Rohit Shrivastava, et al.
Published: (2021-04-01) -
Characterization of an Atypical eIF4E Ortholog in <i>Leishmania</i>, LeishIF4E-6
by: Nitin Tupperwar, et al.
Published: (2021-11-01) -
Gene editing and scalable functional genomic screening in Leishmania species using the CRISPR/Cas9 cytosine base editor toolbox LeishBASEedit
by: Markus Engstler, et al.
Published: (2023-05-01)